477 
Neurocognitive Impairment in a Romanian Cohort of Children and Young Adults Infected with HIV-1 Clade F
D Duiculescu1, Luminita Ene*1, R Burlacu1, C Marin1, G Tardei1, T Marcotte2, R Ellis2, I Everall2, and C Achim2
1Victor Babes Hosp for Infectious Diseases, Bucharest, Romania and 2HIV Neurobehavioral Res Ctr, Univ of California, San Diego, US
Background: The Romanian cohort consists of young
adults who have been living with HIV for approximately 2 decades, having been
infected with clade F as infants. Due to the lack of specific case definition,
we aimed to describe the features HIV encephalopathy (HIVE) in adolescents with
parenterally acquired HIV-infection and to evaluate their current
neurocognitive status.
Methods: We designed a retrospective study (1996 to 2008)
on the prevalence, clinical, and neuroimaging features of HIVE. We have also
evaluated prospectively the neurocognitve deficit in a subgroup of adolescents
based on the current HIV-associated neurocognitive disorders (HAND) criteria.
Results: The original study cohort consisted of 110
children (76 boys), mean age of 11.1±3.7 years. The prevalence of HIVE was
20.1% of AIDS-defining diseases (21.3% pre-HAART and 18.8% during the HAART
period). The most frequent manifestations were cognitive deficit 61.8%,
behavioral disorders 24.5%, pyramidal syndrome 39.1%, and cerebellar syndrome
37.3%. Cerebrospinal fluid (CSF) studies (57 patients) revealed a positive
correlation between pleocytosis and CSF albumin levels ρ = 0.29, p =
0.02. Of 19 patients with HIVE and paired plasma-CSF samples, 12 had higher CSF
than plasma HIV RNA levels (5.42±1.18 log10 copies/mL vs 4.51±1.26
log10 copies/mL, p <0.05). Imaging studies using computed
tomography scanning revealed that brain atrophy was the most frequent finding
(84%), while MRI revealed demyelinating lesions in 2 of 3 of the patients
studied. The mortality was 27.3%, and the risk factors associated with it were
low age at the time of HIVE diagnosis (p = 0.01) and absence of
ART/HAART (p = 0.01). Cognitive evaluation (WISC) between 1996 and 1999,
revealed a reduced IQ in the HIVE group compared to patients without HIVE (62.1
vs 73.9, p = 0.007). The prospective evaluation of neurocognitive
impairment in a subgroup of 43 patients using the current HAND definitions
detected in 60.5% of the subjects various levels of deficit in the 7 cognitive
areas, with 16 patients having minor deficit, 4 patients moderate impairment,
and 6 patients severe impairment.
Conclusions: The high prevalence of HIVE among AIDS-defining
diseases remains significant in the HAART era. High HIV RNA CSF values strongly
correlate with the diagnosis of HIVE. We propose that the current HAND
diagnostic criteria are useful tools in detecting the early stages of
neurocognitive impairment and neurologic deficits in young patients with HIV
clade F.
|